Hormone replacement therapy in military members
Treatments studied
Part of Hormones & metabolism, Mental health clinical trials.
This study is looking at how sex hormone replacement therapy affects active-duty military members and their families. It aims to understand the effects in people with low testosterone or those receiving gender-affirming hormones.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a Department of Defense health care beneficiary (like TRICARE).
- You are between 18 and 65 years old.
- You have been diagnosed with low testosterone or are receiving gender-affirming hormone therapy for at least 6 months.
- You have been on a steady dose of your hormone therapy for at least 6 months.
- You live in the Washington, D.C. area and plan to stay for at least one more year.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how the body handles stress, using different hormone levels to create specific conditions in healthy young adults. It aims to understand the body's response and recovery, which may help people build resilience to stress.
This study looks at how people respond early after starting gender-confirming hormones. It may help doctors understand what changes happen soon after treatment starts and how to manage it safely.
This study looks at how long-term gender-affirming hormone therapy affects your body's metabolism and energy use. Researchers want to understand these changes better to improve care for transgender and gender-diverse people.
This trial tests a testosterone injection (XYOSTED) to see if it's safe and effective for replacing testosterone in teenage boys who have low levels due to a known medical condition. It lasts 52 weeks, with an optional 2-year follow-up.
This study looks at how gender-affirming hormone therapy (estrogen or testosterone) affects the immune system in transgender individuals. Researchers want to understand how these hormones change immune function over time, which could help improve health care for trans people.
This study looks at starting gender-affirming hormone therapy (GAHT) for transgender people who have never had these treatments before. It may help you learn whether this approach is safe and effective for your goals as you begin care.
Hear when a new Hypogonadism trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.